Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions.

Gaud G, Iochmann S, Guillon-Munos A, Brillet B, Petiot S, Seigneuret F, Touzé A, Heuzé-Vourc'h N, Courty Y, Lerondel S, Gruel Y, Reverdiau P.

J Cell Mol Med. 2011 Feb;15(2):196-208. doi: 10.1111/j.1582-4934.2009.00989.x.

2.

Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion.

Iochmann S, Bléchet C, Chabot V, Saulnier A, Amini A, Gaud G, Gruel Y, Reverdiau P.

Clin Exp Metastasis. 2009;26(5):457-67. doi: 10.1007/s10585-009-9245-z. Epub 2009 Mar 7.

PMID:
19267203
3.
4.

Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis.

Tang Z, Geng G, Huang Q, Xu G, Hu H, Chen J, Li J.

Med Oncol. 2010 Sep;27(3):867-75. doi: 10.1007/s12032-009-9298-5. Epub 2009 Sep 10.

PMID:
19763915
5.

Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer.

Rollin J, Iochmann S, Bléchet C, Hubé F, Régina S, Guyétant S, Lemarié E, Reverdiau P, Gruel Y.

Br J Cancer. 2005 Feb 28;92(4):775-83.

6.
7.

Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility.

Stavik B, Skretting G, Aasheim HC, Tinholt M, Zernichow L, Sletten M, Sandset PM, Iversen N.

BMC Cancer. 2011 Aug 17;11:357. doi: 10.1186/1471-2407-11-357.

8.

An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice.

Chen X, Su Y, Fingleton B, Acuff H, Matrisian LM, Zent R, Pozzi A.

Clin Exp Metastasis. 2005;22(2):185-93.

PMID:
16086239
9.

RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.

Feng Y, Hu J, Ma J, Feng K, Zhang X, Yang S, Wang W, Zhang J, Zhang Y.

Eur J Cancer. 2011 Oct;47(15):2353-63. doi: 10.1016/j.ejca.2011.05.006. Epub 2011 Jun 15.

PMID:
21680174
10.
11.

Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.

Beshir AB, Ren G, Magpusao AN, Barone LM, Yeung KC, Fenteany G.

Cancer Lett. 2010 Dec 28;299(2):137-49. doi: 10.1016/j.canlet.2010.08.012. Epub 2010 Sep 19.

12.

Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.

Parmo-Cabañas M, Molina-Ortiz I, Matías-Román S, García-Bernal D, Carvajal-Vergara X, Valle I, Pandiella A, Arroyo AG, Teixidó J.

J Pathol. 2006 Jan;208(1):108-18.

PMID:
16278822
13.

Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer.

Lavergne M, Jourdan ML, Blechet C, Guyetant S, Pape AL, Heuze-Vourc'h N, Courty Y, Lerondel S, Sobilo J, Iochmann S, Reverdiau P.

FEBS Open Bio. 2013 Jun 27;3:291-301. doi: 10.1016/j.fob.2013.06.004. Print 2013.

14.

ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.

Chen L, Pan Y, Gu L, Nie Z, He B, Song G, Li R, Xu Y, Gao T, Wang S.

Exp Biol Med (Maywood). 2013 Aug 1;238(8):903-12. doi: 10.1177/1535370213493706. Epub 2013 Jul 4.

PMID:
23828593
15.

Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases.

Liu PL, Tsai JR, Charles AL, Hwang JJ, Chou SH, Ping YH, Lin FY, Chen YL, Hung CY, Chen WC, Chen YH, Chong IW.

Mol Nutr Food Res. 2010 Jul;54 Suppl 2:S196-204. doi: 10.1002/mnfr.200900550.

PMID:
20461740
16.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

17.

Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced.

Hellevik T, Pettersen I, Berg V, Winberg JO, Moe BT, Bartnes K, Paulssen RH, Busund LT, Bremnes R, Chalmers A, Martinez-Zubiaurre I.

Radiat Oncol. 2012 Apr 13;7:59. doi: 10.1186/1748-717X-7-59.

18.

Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2.

Choi J, Choi K, Benveniste EN, Rho SB, Hong YS, Lee JH, Kim J, Park K.

Cancer Res. 2005 Jul 1;65(13):5554-60. Erratum in: Cancer Res. 2006 Jan 15;66(2):1250. Rho, Seung Bae [added].

19.

CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.

Bretz N, Noske A, Keller S, Erbe-Hofmann N, Schlange T, Salnikov AV, Moldenhauer G, Kristiansen G, Altevogt P.

Clin Exp Metastasis. 2012 Jan;29(1):27-38. doi: 10.1007/s10585-011-9426-4. Epub 2011 Oct 8.

PMID:
21984372
20.

Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms.

Hancox RA, Allen MD, Holliday DL, Edwards DR, Pennington CJ, Guttery DS, Shaw JA, Walker RA, Pringle JH, Jones JL.

Breast Cancer Res. 2009;11(2):R24. doi: 10.1186/bcr2251. Epub 2009 Apr 30.

Items per page

Supplemental Content

Write to the Help Desk